AI assistant
Sending…
ASSEMBLY BIOSCIENCES, INC. — Director's Dealing 2018
Jan 3, 2018
33081_dirs_2018-01-03_a8688da8-e4e4-4993-ada4-63f168269f47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2018-01-01
Reporting Person: Colonno Richard James (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-01 | Common Stock | A | 25000 | — | Acquired | 25000 | Direct |
Footnotes
F1: Represents shares of common stock issuable under a performance-based Restricted Stock Unit (RSU) Award dated December 8, 2017 that was granted under Assembly Biosciences, Inc.'s Amended and Restated 2014 Stock Incentive Plan. On January 1, 2018, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in full on August 1, 2018, assuming the Reporting Person's continuous service through August 1, 2018.
More from ASSEMBLY BIOSCIENCES, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 26
Share Issue/Capital Change
2026
May 22
Capital/Financing Update
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
Mar 30
Capital/Financing Update
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2025
Dec 8